Protalix BioTherapeutics Inc.

XASE:PLX

2.83

+0.04 (+1.43%)

7:59:37 PM EDT: $2.79 -0.04 (-1.41%)

Market Cap (Intraday)	230.85M
Current PE	42.80
Forward PE	94.33
2yr Forward PE	14.15

See more stats

Estimates Current Quarter

Revenue	$18.3 Million
Adjusted EPS	$0.04

See more estimates

10-Day MA	$2.85
50-Day MA	$2.52
200-Day MA	$1.97

See more pivots

Protalix BioTherapeutics Inc. Stock, XASE:PLX

2 University Plaza, Suite 100, Hackensack, New Jersey 07601

United States of America

Phone: +1.201.696.9345

Number of Employees: 213

http://www.protalix.com

Description

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.